Role of CD4 cell counts in predicting disease outcome in covid positive patients
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/02/031096
- Lead Sponsor
- Government Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patient diagnosed as covid 19 infected either by RTPCR or Rapid antigen test.
Patients diagnosed as Covid 19 positive will be divided into Group A and Group B as per Revised Guidelines on Clinical Management of COVID â?? 19. Ministry of Health & Family Welfare Directorate General of Health Services (EMR Division) Government of India. (12)
Group A â?? RT PCR or RAT positive
Severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock will be considered as severe Covid infection
Group B - RT PCR or RAT positive
Uncomplicated illness and mild pneumonia will be considered as non-severe (mild/moderate) Covid infection
HIV infected patients
Patients on immunosuppressive therapy or any disease or therapy known to affect the CD4 counts e.g. autoimmune disease, tuberculosis, patients on chronic steroids, etc
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method